Arta M. Monjazeb - Concepedia

Author

Arta M. Monjazeb

Also Known As

A. M. Monjazeb, A. Monjazeb, A.M. Monjazeb, ARTA M. MONJAZEB, Arta M Monjazeb, Arta M. Monjazeb, Arta Monir Monjazeb, Arta Monjazeb, Arta M. Monjazeb, Crowley, Jiwon Sarah

209

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

University of California, Davis University of California Davis Medical Center UC Davis Comprehensive Cancer Center University of Minnesota National Cancer Institute

About

Arta M. Monjazeb is an author at University of California, Davis specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	30	2.4K
2	Health Sciences	11	13	400
3	Engineering	1	1	34
4	Allergy	1	1	154
5	Biomedical Engineering	1	1	34

Arta M. Monjazeb

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Ziming Wang, Ethan G. Aguilar, Jesus I. Luna, Nature Medicine ObesityCancer ImmunosurveillancePd-1 Checkpoint BlockadeT Cell FunctionMedicine	2018	806
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype Erik Ames, Robert J. Canter, Steven K. Grossenbacher, The Journal of Immunology Cell TherapyNatural Killer CellsCancer ImmunosurveillanceMedicineImmunology	2015	234
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion Nian Jiang, Bowen Xie, Wenwu Xiao, Nature Communications	2022	226
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial Jonathan D. Schoenfeld, Anita Giobbie‐Hurder, Srinika Ranasinghe, The Lancet Oncology MedicinePrevious PdBronchial NeoplasmImmune Checkpoint InhibitorCancer Treatment	2022	225
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy Myriam N. Bouchlaka, Gail D. Sckisel, Mingyi Chen, The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyImmunologic MechanismImmunotherapy	2013	154
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells Demet Candas-Green, Bowen Xie, Jie Huang, Nature Communications	2020	142
Outcomes of Patients With Esophageal Cancer Staged With [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection? Arta M. Monjazeb, Gregory Riedlinger, Mebea Aklilu, Journal of Clinical Oncology	2010	137
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice Annie Mirsoian, Myriam N. Bouchlaka, Gail D. Sckisel, The Journal of Experimental Medicine	2014	137
Minimal PD-1 expression in mouse and human NK cells under diverse conditions Sean J. Judge, Cordelia Dunai, Ethan G. Aguilar, Journal of Clinical Investigation Adaptive Immune SystemT-regulatory CellImmunologyImmunoeditingPathology	2020	135
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial Robert J. Canter, Steven K. Grossenbacher, Jennifer A. Foltz, Journal for ImmunoTherapy of Cancer	2017	122

Page 1